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The past few decades have seen dramatic 
increases in obesity prevalence in all age groups 
worldwide (Kelly et al. 2008; Wang and 
Lobstein 2006). There is substantial evidence 
that obesity risk may begin very early in life; 
> 40 studies have documented rapid weight 
gain in the first few months after birth to be 
associated with obesity later in life (Akaboshi 
et al. 2008; Blair et al. 2007; Botton et al. 
2008; Chomtho et al. 2009; Demerath et al. 
2009; Dubois and Girard 2006; Durmuş 
et al. 2010; Ekelund et al. 2006; Eriksson 
et al. 2008; Goodell et al. 2009; Hitze et al. 
2010; Kain et al. 2009; Karaolis-Danckert 
et al. 2006; Lamb et al. 2010; Ong and Loos 
2006; Ong et al. 2009; Taveras et al. 2009; 
Toschke et al. 2004) or related metabolic 
disorders (Cournil et al. 2009; EURODIAB 
Substudy 2 Study Group 2002; Harder et al. 
2009; Huxley et al. 2000; Law et al. 2002; 
Leunissen et al. 2009). Although feeding prac-
tices likely play a role (Koletzko et al. 2009; 
Worobey et al. 2009), there is considerable 
uncertainty regarding other factors that may 
program this rapid infant growth.
There is emerging interest in the possibility 
that perinatal exposure to certain xenobiotic 
chemicals may be obesogenic (Grün and 
Blumberg 2009; Heindel and vom Saal 
2009). Substantial evidence suggests that ges-
tational tobacco exposure is related to excess 
weight gain and later obesity (Mendez et al. 
2008; Oken et al. 2008). Laboratory stud-
ies suggest that prenatal exposure to some 
endocrine-disrupting compounds (EDCs) may 
also promote obesity. For example, despite 
similar dietary intakes, excess postnatal weight 
gain has been observed in mice exposed peri-
natally to bisphenol A (BPA) or organotins 
(Grün et al. 2006; Rubin et al. 2001; Somm 
et al. 2009). However, few EDCs have been 
examined in laboratory studies thus far. More 
important, there are limited empirical data 
linking such exposures to obesity in humans 
(Elobeid and Allison 2008). One recent study 
(Smink et al. 2008) reported an association 
between obesity at 6.5 years of age and pre-
natal hexachlorobenzene (HCB) exposure, 
and two reported fetal exposure to 2,2-bis(p-
chlorophenyl)-1,1-dichloroethylene (DDE) 
to be associated with higher body mass index 
(BMI) at 3 years of age (Verhulst et al. 2009) 
or in adulthood (Karmaus et al. 2009). It 
remains uncertain whether such exposures in 
humans may program rapid weight gain begin-
ning in infancy.
In this study we examined the relation-
ship between rapid weight gain in the first 
6 months of life and prenatal exposure to 
several organochlorine compounds (OCs) 
with endocrine-disrupting properties, includ-
ing DDE and HCB. Because maternal weight 
status may modify children’s risk of obesity, 
perhaps due to differential feeding practices 
(Buyken et al. 2008) or higher OC concentra-
tions among those with higher BMIs (Jakszyn 
et al. 2009), we examined possible effect 
modification by prepregnancy overweight/
obesity (hereafter overweight) a priori. We 
also examine how rapid early weight gain and 
OC exposure relate to BMI status attained in 
the second year of life.
Materials and Methods
Data come from the Environment and 
Childhood Project [Infancia y Medio-
Ambiente (INMA)] in Sabadell (Catalonia, 
Spain), a population-based birth cohort that 
enrolled 657 women in 2004–2006, during 
the first trimester of pregnancy (Ribas-Fitó 
et al. 2006). Women were recruited from 
public health centers during their first ultra-
sound visit (mean ± SD, 13.5 ± 1.7 weeks’ 
gestation); 99.5% of Spaniards have public 
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Ba c k g r o u n d: Although it has been hypothesized that fetal exposure to endocrine-disrupting 
chemicals may increase obesity risk, empirical data are limited, and it is uncertain how early in life 
any effects may begin.
oBjectives: We explored whether prenatal exposure to several organochlorine compounds (OCs) 
is associated with rapid growth in the first 6 months of life and body mass index (BMI) later 
in infancy.
Me t h o d s : Data come from the INMA (Infancia y Medio-Ambiente) Child and Environment 
birth cohort in Spain, which recruited 657 women in early pregnancy. Rapid growth during the 
first 6 months was defined as a change in weight-for-age z-scores > 0.67, and elevated BMI at 
14 months, as a z-score ≥ the 85th percentile. Generalized linear models were used to estimate the 
risk of rapid growth or elevated BMI associated with 2,2-bis(p-chlorophenyl)-1,1-dichloroethylene 
(DDE), hexachlorobenzene, β-hexachlorohexane, and polychlorinated biphenyls in first-trimester 
maternal serum.
re s u l t s: After multivariable adjustment including other OCs, DDE exposure above the first 
quartile was associated with doubling of the risk of rapid growth among children of normal-weight 
(BMI < 25 kg/m2), but not overweight, mothers. DDE was also associated with elevated BMI at 
14 months (relative risk per unit increase in log DDE = 1.50; 95% confidence interval, 1.11–2.03). 
Other OCs were not associated with rapid growth or elevated BMI after adjustment.
co n c l u s i o n s: In this study we found prenatal DDE exposure to be associated with rapid weight 
gain in the first 6 months and elevated BMI later in infancy, among infants of normal-weight 
mothers. More research exploring the potential role of chemical exposures in early-onset obesity 
is needed.
key w o r d s : β-hexachlorohexane, body mass index, dichlorodiphenyldichloroethylene, hexachloro-
benzene, infant, obesity, polychlorinated biphenyls, prenatal, weight gain. Environ Health Perspect 
119:272–278 (2011).  doi:10.1289/ehp.1002169 [Online 5 October 2010]Prenatal organochlorines and growth
Environmental Health Perspectives  •  v o l u m e  119 | n u m b e r 2 | February 2011  273
health insurance, and an estimated 70–90% 
of women use public health services during 
pregnancy (Regidor et al. 2008). The partici-
pation rate was 60%. Questionnaires were 
administered by trained interviewers during 
the first and third trimester, at delivery, and 
at 6 and 14 months after birth to assess health 
and feeding behaviors, health status, socio-
demographic characteristics, reproductive his-
tory, and other factors. Maternal blood was 
collected at recruitment. Birth outcomes were 
available for 616 women (94%), including 
599 term births (≥ 37 weeks’ gestation) eligible 
for this analysis. Of these, 518 (86%) had data 
on infant growth, OCs, and key covariates and 
were included in the analysis sample. Ethical 
approval was obtained from the Clinical 
Research Ethical Committee of the Municipal 
Institute of Health Care, and informed con-
sent was obtained from all subjects.
Infant anthropometry. Infant weight (near-
est gram) and length (nearest 0.1 cm) were mea-
sured at birth and at 14 months by trained staff 
in using standard protocols (Lohman 1988). 
Infants below the 10th percentile of a Spanish 
reference were classified as small for gestational 
age (SGA) (Carrascosa et al. 2004). Repeated 
measures of infant weight throughout the first 
6 months were abstracted from medical records. 
Weight gain from birth to 6 months was esti-
mated in two ways. First, weight meas  ures were 
used to construct sex-specific growth curves 
using mixed models with random intercept and 
slope after transformations based on fractional 
polynomials (Royston 1995). These curves were 
used to estimate weight at 6 months of age for 
infants not measured within ±14 days of their 
exact 6-month anniversary (16.2% of the sam-
ple). The correlation between measured and 
predicted 6-month weight was 0.96; restricting 
the analysis to infants with measured weights 
yielded very similar results (data not shown). 
Second, weight measured within ±1 month of 
the 6-month anniversary was used to estimate 
average daily weight gain through 6 months 
(95.8% of the analysis sample). Defining rapid 
growth as the highest tertile of average daily 
weight gain yielded very similar results (data 
not shown).
To define rapid growth, weight at birth 
and at 6 months of age was standardized based 
on the World Health Organization referent (de 
Onis et al. 2009). Rapid growth was defined as 
a z-score change of > 0.67 between birth and 
6 months of age, and slow growth was defined 
as a z-score change of < 0.67 (Monteiro and 
Victora 2005). Results were consistent with 
defining rapid growth using internal stan-
dardization of the sample or the U.S. Centers 
for Disease Control and Prevention referent 
(Kuczmarski et al. 2002) (data not shown). 
Additionally, to estimate effects of rapid early 
growth and OC exposure on later nutritional 
status, we estimated associations with BMI-for-
age z-scores at 14 months of age. BMI z-scores 
≥ 1.44, corresponding to the 85th percentile 
typically used to define child overweight, were 
defined as elevated. Consistent results were 
obtained classifying 14-month weight status 
using the U.S. referent and weight-for-length 
z-scores (data not shown).
OC exposures. Maternal first-trimester 
serum levels of DDE, HCB, DDT [2,2-
bis(p-chlorophenyl)-1,1,1-trichloroethane], 
β-hexachlorohexane (βHCH), and polychlo-
rinated biphenyl (PCB) congeners 118, 138, 
153, and 180 were measured by the Public 
Health Laboratory of the Basque government, 
using methods described elsewhere (Goñi 
et al. 2007). Because 99% of the sample 
had DDT levels below the limits of detec-
tion (LODs), this OC was excluded from 
the analysis. All subjects had detectable lev-
els of DDE. For the remaining OCs, with 
up to approximately 10% below the LODs, 
  levels were adjusted for lipids as prescribed by 
Phillips et al. (1989). Values below the LOD 
were imputed as LOD/2.
Other variables. Maternal age, parity, edu-
cation level, prepregnancy weight, country of 
origin, and occupation, along with paternal 
height, weight, and occupation, were reported 
by mothers at recruitment. Occupation data 
were used to assess social class (Instituto 
Nacional de Estadística 1994). Maternal 
height (nearest 0.5 cm) was used to calcu-
late prepregnancy BMI (weight in kilograms/
height in square meters) to classify women as 
normal weight, overweight (BMI ≥ 25 kg/m2), 
or obese (≥ 30 kg/m2). Weight gains through-
out pregnancy from prenatal visit records were 
used to validate prepregnancy weight and to 
estimate gestational weight gain adequacy 
(Institute of Medicine 2009). Information on 
tobacco use throughout pregnancy was self-
reported in the first and third trimesters, child 
sex was recorded at birth, and breast-feeding 
duration was reported in postnatal question-
naires. All analyses of rapid growth were con-
ducted in the sample with complete data for 
the main exposure, outcome, and covariates 
(n = 518); analyses of BMI at 14 months had 
slightly fewer observations because of missing 
values for this variable (n = 502). Within the 
analysis sample with complete exposure and 
outcome data, there were few additional miss-
ing values for covariates (n = 17 and n = 16, 
respectively, for analyses of rapid growth and 
BMI at 14 months).
Statistical analysis. Characteristics of rapid 
versus average/slow growers, including maternal 
OC levels and infant anthropometric measures, 
were described using means ± SD or propor-
tions, with chi-square, analysis of variance, 
Student’s t-test, or Wilcoxon–Mann–Whitney 
tests applied as appropriate to assess statisti-
cal significance (p < 0.05 considered signifi-
cant for main effects). Because maternal weight 
status was found to modify the effect of OC 
exposures on rapid growth (p < 0.10 used to 
define significance for interactions), OC levels 
were also described separately among normal-
weight versus overweight women. Because dis-
tributions were skewed, geometric means were 
used to describe levels of OCs and significance 
assessed using Wilcoxon–Mann–Whitney 
tests on log-transformed data. Relationships 
among OCs were assessed using Spearman’s 
  correlations and log-transformed data.
Generalized linear models (GLMs) for 
binary outcomes were used to estimate rela-
tive risks (RRs) and 95% confidence intervals 
(CIs) for associations between increasing lev-
els of each OC and rapid early growth (Zou 
2004). To assess the linearity of relation-
ships, generalized additive models were used 
to examine the shape of the dose–response 
relationship adjusted for relevant confounders 
(Hastie and Tibshirani 1995). When relation-
ships were nonlinear, OC quartiles were used; 
log-transformed continuous variables were 
used for linear relationships. GLMs were also 
used to assess how both rapid early growth 
and prenatal OCs—separately as well as 
adjusting simultaneously—related to the risk 
of elevated BMI at 14 months.
Maternal characteristics (age, education, 
social class, parity, prepregnancy weight status, 
gestational weight gain, smoking during preg-
nancy, weeks of gestation at blood sampling, 
triglycerides, cholesterol) and other poten-
tial influences on postnatal growth, including 
child’s sex, gestational age at birth and SGA 
status, paternal height and weight, and breast-
feeding duration, were considered as potential 
confounders of associations between prenatal 
OCs and infant growth. Covariates retained 
in the final models included infants’ exact age 
at measurement and variables that resulted in 
a change in estimate ≥ 10%.
In supplementary analyses, we confirmed 
that excluding SGA (n = 28) or low-birth-
weight (n = 15) infants, among whom catch-up 
growth may be normative, did not meaning-
fully change results. Results for individual 
PCB congeners, similar to those for the sum 
of PCBs, are not shown. Excluding women 
born outside Spain (n = 50), who may dif-
fer in terms of OC exposures and infant care 
practices, and excluding nonwhite (n = 13) or 
underweight (BMI < 18; n = 30) mothers at 
the start of pregnancy also had no meaning-
ful influence on results (data not shown).We 
examined whether child sex modified effects of 
OCs on growth; interactions did not reach sig-
nificance (p > 0.10). Finally, we confirmed that 
associations did not change when meaningfully 
restricting the referent to average growers (n = 
276, 53.28% of the sample) rather than aver-
age/slow growers (data not shown). All analy-
ses used STATA, version 10.1 (StataCorp LP, 
College Station, TX, USA).Mendez et al.
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Results
Though rapid growers weighed less at birth 
(mean difference, 293 g), by 6 months of age 
these infants were significantly heavier than 
were average/slow growers (891 g) (Table 1). 
Rapid growers remained taller and heavier at 
14 months.
OCs and rapid growth among normal-
weight versus overweight mothers. HCB and 
βHCH were highly correlated (Spearman’s 
r = 0.79, log-transformed variables), with 
more moderate correlations with DDE 
(HCB–DDE, r = 0.29; βHCH–DDE, r = 
0.39; PCBs–DDE, r = 0.39) and PCBs 
(PCBs–HCB, r = 0.51; PCBs–βHCH, r = 
0.40). Overall, mean levels of all OCs were 
similar among rapid and average/slow growers 
(Table 2). However, among infants of women 
of normal prepregnancy weight, mean levels 
of DDE, HCB, and βHCH were significantly 
higher among rapid growers than among 
average/slow growers (p < 0.05). Neither the 
sum of PCBs nor individual PCBs (data not 
shown) were associated with rapid growth. In 
contrast, among infants of women overweight 
before pregnancy, mean OC levels were lower 
among rapid growers than among average/
slow growers, although differences were not 
statistically significant.
Among infants whose mothers were of 
normal prepregnancy weight, associations 
between increasing prenatal DDE expo-
sure and rapid growth were nonlinear, with 
an increasing predicted risk followed by an 
apparent decline in the top 3% of expo-
sure [> 750 ng/g; ~ 6.6 ng/g on the log 
scale; see Supplemental Material, Figure 1 
(doi:10.1289/ehp.1002169)]. Therefore, OC 
exposures were categorized as quartiles to 
examine dose–response relationships between 
OCs and rapid growth (Table 3). Except for 
PCBs (data not shown), which were essentially 
unrelated to rapid growth (21.3%/25.2% 
rapid growers in the top/bottom quartile), 
risk of rapid growth among infants of nor-
mal-weight mothers rose with increasing 
quartiles of exposure to each OC. Disparities 
in rapid growth in this group were greatest 
for DDE, with a nearly 3 times greater fre-
quency (29.8% vs. 11.7%; p < 0.05) in the 
highest than in the lowest quartiles. After 
multivariable adjustment, exposures above 
the lowest quartile of DDE were associated 
with a 2.4 times greater risk of rapid growth 
among normal-weight mothers (p < 0.05). 
Associations were similar and remained signif-
icant after adjusting for other OCs. For HCB 
and βHCH, however, associations with rapid 
growth were weakened and not significant 
after adjusting for DDE (Table 3). Because 
HCB and βHCH were highly correlated, we 
examined results adjusting for either OC but 
not both simultaneously; findings were very 
similar (data not shown).
In the group of infants with normal-
weight mothers, risk of rapid growth associ-
ated with the top quartile of DDE exposure 
was slightly strengthened by excluding the 
subjects (n = 15) with DDE > 750 ng/g 
(6.6 ng/g, log scale), none of whom were 
rapid growers (RR, 2.76; 95% CI, 1.36–5.62). 
Alternatively, excluding foreign-born mothers 
(73.3% of subjects at this level of exposure) 
had little effect (fourth vs. first quartile: RR = 
2.35; 95% CI, 1.15–5.01). Results were also 
consistent after excluding n = 28 SGA infants 
(RR = 2.65; 95% CI, 1.26–5.58), or n = 15 
low-birth-weight infants (RR = 3.04; 95% 
Table 1. Characteristics of rapid, average, and slow growers.
Characteristic Average/slow growers (n = 393) Rapid growers (n = 125) p-Valuea
Male sex  201 (51.2) 64 (51.2%) 0.991
Birth characteristics
Birth weight (kg)  3.34 ± 0.02 3.04 ± 0.04 < 0.001
Birth weight z-score  0.069 ± 0.039 –0.574 ± 0.076 < 0.001
Birth length (cm) 49.69 ± 0.09 48.98 ± 0.16 < 0.001
Gestational age (weeks)  39.90 ± 0.06 39.53 ± 0.10 0.003
SGA  17 (4.34) 21 (16.80) < 0.001
Low birth weight (< 2,500 g)  3 (0.76) 12 (9.60) < 0.001
Infant growth at 6 and 14 months
Weight at 6 months (kg) 7.42 ± 0.04 8.29 ± 0.08 < 0.001
Weight z-score at 6 months  –0.28 ± 0.80 0.68 ± 0.83 < 0.001
Weight at 14 months (kg) 10.07 ± 0.05 11.12 ± 0.12 < 0.001
Length at 14 months (cm)  77.37 ± 0.15 78.75 ± 0.24 < 0.001
BMI at 14 months (kg/m2) 16.64 ± 1.33 18.26 ± 1.51 < 0.001
Weight z-score (14 months)  0.12 ± 0.85 0.96 ± 0.99 < 0.001
Length z-score (14 months)  –0.20 ± 1.04 0.33 ± 0.96 < 0.001
BMI z-score (14 months)  0.34 ± 0.82 1.06 ± 0.95 < 0.001
Parental characteristics
Maternal age (years)  31.78 ± 0.21 31.63 ± 0.41 0.983
Maternal height (m)  1.62 ± 0.00 1.63 ± 0.01 0.592
Maternal parity (firstborn)  216 (54.96) 76 (60.80) 0.252
Maternal overweight/obesity  112 (28.5) 32 (25.6) 0.529
Mother born outside Spain  38 (9.74) 12 (9.76) 0.997
Maternal education 
Primary or less 94 (23.98) 42 (33.87)
Secondary 166 (42.35) 48 (38.71)
University 132 (33.67) 34 (27.42) 0.084
Manual occupation, motherb  181 (46.1) 66 (52.8) 0.189
Paternal height (m)  1.76 ± 0.004 1.77 ± 0.007 0.257
Paternal overweight/obesity  209 (53.7) 71 (57.7) 0.438
Manual occupation, father  206 (56.0) 73 (61.3) 0.304
Values are mean ± SD or n (%). Data are for the complete analysis data set; missing values for individual covariates 
ranged from 2 to 14 observations, with n = 17 observations lost due to missing values for all covariates combined. There 
was no significant difference in the proportion missing among average/slow versus rapid growers (p-values, two-sam-
ple test for proportions > 0.3). World Health Organization data (de Onis et al. 2009) were used to derive z-scores.
at-Test (for normally distributed) or Wilcoxon–Mann–Whitney for continuous variables; chi-square test for categorical 
variables. bManual occupation: skilled or partially skilled manual workers during pregnancy or most recent job before 
pregnancy.
Table 2. Lipid-adjusted OC levels in first-trimester maternal serum for rapid and average/slow growers 
[geometric mean (95% (CI)].
OC Percent < LODa Average/slow growers Rapid growers
All infants, ng/g lipid (n = 518)
DDE 0.0 125.40 (115.03–136.70) 135.59 (119.48–153.87)
HCB 8.5 23.38 (19.00–28.78) 26.53 (18.47–38.13)
βHCH 10.0 17.79 (14.37–22.04) 20.46 (13.98–29.94)
ΣPCBs 7.7 43.72 (36.36–52.56) 47.99 (34.84–66.11)
Normal-weight mothers, ng/g lipid (n = 374)
DDE* 0.0 120.76 (108.70–134.15) 146.78 (127.97–168.35)
HCB* 9.1 18.82 (14.51–24.42) 31.21 (21.89–44.50)
βHCH* 10.4 15.09 (11.57–19.70) 25.54 (17.55–37.19)
ΣPCBs 7.2 45.20 (36.02–56.73) 66.96 (51.20–87.58)
Overweight mothers, ng/g lipid (n = 144)
DDE 0.0 137.84 (118.71–160.07) 107.68 (80.46–144.10)
HCB 6.9 40.28 (29.64–54.74) 16.56 (6.11–44.89)
βHCH 9.0 26.89 (19.20–37.66) 10.73 (3.85–29.86)
ΣPCBs 9.0 40.21 (29.50–54.80) 18.22 (7.14–46.51)
ΣPCBs refers to sum of congeners 118, 138, 153, and 180. Among normal-weight mothers, n = 93 rapid growers (24.9%); 
among overweight mothers, n = 32 rapid growers (22.2%). All subjects had detectable levels of DDE.
aLOD = 0.071 ng/mL serum for all OCs; values below this level set to LOD/2.
*Wilcoxon–Mann–Whitney p-value < 0.05.Prenatal organochlorines and growth
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CI, 1.45–6.35). Using log DDE as a continu-
ous measure, the RR per one-unit increase 
(2.72 ng/g on the original scale) was 1.24 
(95% CI, 1.02–1.50) for all subjects and was 
1.60 (95% CI, 1.22–2.09) after excluding the 
top 3% of exposure. Compared with infants of 
normal-weight mothers, infants in the smaller 
sample with overweight mothers showed asso-
ciations that were inverse but not significant.
To maximize cell sizes in models stratified 
by maternal overweight, we used tertiles to 
explore whether associations between OCs and 
rapid growth varied by infant sex. Although 
DDE–child sex interaction terms did not 
achieve statistical significance (p = 0.17 over-
all; p = 0.14 among normal-weight mothers), 
DDE was more strongly associated with rapid 
growth in boys than in girls. Among boys 
with normal-weight mothers, the risk of rapid 
growth in the intermediate and highest tertiles 
of DDE was more than three times higher 
than in the lowest tertile (highest vs. lowest 
tertile: multivariable-adjusted RR = 3.61; 95% 
CI, 1.36–9.56; n = 6 rapid growers in the ref-
erent group). The intermediate (RR = 1.71; 
95% CI, 0.90–3.23) but not the highest (RR 
= 0.90; 95% CI, 0.40–2.08) tertile of DDE 
was positively, although not significantly, asso-
ciated with rapid growth in girls (n = 13 rapid 
growers in the referent group).
OCs,  rapid  growth,  and  BMI  at 
14 months. At 14 months, 13.9% of infants 
had elevated BMI z-scores. Rapid growers 
were more likely than were average/slow 
growers to have an elevated BMI z-score 
(35.5% vs. 7.1%; p < 0.05). After multivar-
iable adjustment, rapid growth in the first 
6 months was associated with a 5 times higher 
risk of elevated 14-month BMI, with simi-
lar associations among normal-weight and 
overweight mothers. In addition, prenatal 
DDE, but not other OCs, was associated with 
elevated BMI z-scores at 14 months among 
infants of normal-weight mothers (Table 4).
Discussion
There is growing awareness that factors aside 
from increasing intakes of energy-dense foods 
and declining physical activity may play key 
roles in the obesity epidemic (McAllister et al. 
2009). It is also increasingly apparent that 
long-term obesity risk may be evident from 
rapid growth initiated in the first months of 
life (Ong and Loos 2006). In this study, we 
found that among mothers not overweight or 
obese before pregnancy, higher DDE levels 
in first-trimester serum were strongly asso-
ciated with two indicators of early obesity 
risk in their children: rapid weight gain in 
the first 6 months of life and elevated BMI 
z-scores at 14 months. These results are con-
sistent with two earlier studies that reported 
associations between prenatal DDE exposure 
and obesity later in life (Karmaus et al. 2009; 
Verhulst et al. 2009). However, this analysis 
suggests, to our knowledge for the first time, 
that fetal DDE exposure may promote rapid 
growth starting in the immediate postnatal 
period, consistent with the hypothesis that 
early-life exposure to EDCs may promote 
obesogenic changes in metabolism (Heindel 
and vom Saal 2009).
Regardless of DDE exposure levels and 
maternal prepregnancy weight status, children 
with rapid growth in the first months of life 
had a 5 times higher risk of attaining BMIs 
exceeding the 85th percentile by 14 months 
of age. Although changes in feeding and 
other care practices could influence future 
growth trajectories in these children (Karaolis-
Danckert et al. 2006), numerous studies 
Table 3. Maternal OC levels and risk of rapid infant weight gain: number of rapid growers in each exposure group.
Normal-prepregnancy-weight mothers (n = 374) Overweight/obese mothers (n = 144)
Multivariable adjusted Plus all OCsa 
[RR (95% CI)]
Multivariable adjusted Plus all OCsa 
[RR (95% CI)] OC quartile n (%) RR (95% CI) n (%) RR (95% CI)
DDE (ng/g lipid)
≤ 71.71 11 (11.7) 1.00 1.00 14 (38.9) 1.00 1.00
71.71–116.92 27 (28.7) 2.42 (1.25–4.67) 2.21 (1.14–4.29) 5 (14.3) 0.48 (0.19–1.23) 0.61 (0.22–1.69)
116.92–186.17 27 (29.3) 2.47 (1.24–4.92) 2.21 (1.07–4.54) 8 (21.1) 0.66 (0.29–1.54) 0.87 (0.41–1.87)
> 186.17 28 (29.8) 2.47 (1.22–5.00) 2.16 (1.05–4.45) 5 (14.3) 0.43 (0.18–1.06) 0.43 (0.15–1.24)
HCB (ng/g lipid)
≤ 22.84 20 (18.0) 1.00 1.00 8 (42.1) 1.00 1.00
22.84–41.00 20 (21.7) 1.17 (0.66–2.08) 0.92 (0.50–1.69) 10 (27.0) 0.46 (0.21–0.99) 0.17 (0.07–0.45)
41.00–66.28 26 (28.0) 1.54 (0.90–2.64) 1.14 (0.60–2.17) 5 (13.5) 0.21 (0.08–0.52) 0.10 (0.03–0.35)
 > 66.28 27 (34.6) 1.78 (0.96–3.32) 1.20 (0.56–2.56) 9 (17.6) 0.19 (0.07–0.57) 0.11 (0.03–0.51)
 βHCH (ng/g lipid)
≤ 21.70 16 (15.8) 1.00 1.00 8 (27.6) 1.00 1.00
21.70–32.23 25 (25.0) 1.67 (0.95–2.93) 1.45 (0.81–2.62) 10 (34.5) 1.19 (0.48–2.96) 3.88 (1.40–10.70)
32.23–47.28 22 (24.7) 1.53 (0.83–2.85) 1.13 (0.54–2.36) 6 (14.6) 0.44 (0.16–1.18) 1.95 (0.60–6.36)
 > 47.28 30 (35.7) 2.08 (1.11–3.87) 1.42 (0.67–3.01) 8 (17.8) 0.52 (0.16–1.67) 2.02 (0.63–6.48)
Multivariable model adjusted for exact age at examination, gestational age, any breast-feeding at 6 months, firstborn child, maternal smoking during pregnancy, education, and maternal 
age at delivery. 
aAdditionally adjusted for quartiles of the other two OCs shown. 
Table 4. Associations for rapid early growth, maternal OC levels, and elevated BMI z-score (≥ 1.44) at 14 months [RR (95% CI)].
Variable  All mothers (n = 502)
Normal-prepregnancy-
weight mothers (n = 365)
Overweight/obese 
mothers (n = 137)
Interaction p-value 
(× maternal weight status)
Multivariable models
DDE (per log ng/g lipid) 1.22 (0.96–1.55) 1.64 (1.24–2.18) 0.93 (0.60–1.45) 0.086
HCB (per log ng/g lipid) 0.97 (0.86–1.10) 1.02 (0.88–1.18) 0.74 (0.63–0.87) 0.680
βHCH (per log ng/g lipid) 1.03 (0.93–1.15) 1.06 (0.90–1.23) 0.97 (0.84–1.12) 0.678
Rapid growth in the first 6 months 4.71 (3.02–7.35) 5.18 (2.92–9.18) 5.02 (2.56–9.85) 0.420
Mutually adjusted contaminants
DDE (per log ng/g lipid) 1.40 (1.12–1.75) 1.50 (1.11–2.03) 1.22 (0.81–1.84) 0.270
HCB (per log ng/g lipid) 1.00 (0.85–1.17) 0.99 (0.85–1.15) 0.91 (0.74–1.12) 0.340
βHCH (per log ng/g lipid) 0.96 (0.81–1.12) 0.92 (0.78–1.09) 0.95 (0.76–1.18) 0.601
Rapid growth in the first 6 months 4.85 (3.12–7.54) 5.41 (2.88–10.15) 4.40 (2.09–9.28) 0.592
Data are multivariable-adjusted RRs (95% CIs) for likelihood of having an elevated BMI z-score at 14 months. All models adjusted for exact age at examination, maternal country of birth, 
maternal age at delivery, smoking during pregnancy, and parental overweight; rapid growth was included in all models along with either individual or multiple contaminants, as indicated.Mendez et al.
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suggest heavier weight status at 1–2 years is 
predictive of later obesity (Baird et al. 2005).
The “environmental obesogen” hypoth-
esis postulates that the developmental period 
is a vulnerable window during which tran-
sient environmental exposures may alter the 
regulation of weight or adiposity over the 
long term, perhaps as a consequence of epi-
genetic changes influencing gene expression 
or protein regulation (Heindel and vom Saal 
2009; Lee et al. 2009). In vitro and animal 
experiments suggest that some EDCs may 
up  regulate adipogenesis or promote fat stor-
age through mechanisms such as the acti-
vation of retinoid-X receptor, peroxisome 
proliferator activated receptor-γ, or gluco-
corticoid receptor pathways or by disruption 
of estrogen receptor signaling (Grün and 
Blumberg 2009; Sargis et al. 2010). The issue 
is of concern because exposure to many EDCs 
is widespread, as a result of long half-lives 
and extensive use in agriculture and indus-
try (Lang et al. 2008; Wilson et al. 2003). 
Despite evidence of obesogenicity for a few 
chemicals in animal studies, however, few 
empirical data have linked such exposures to 
obesity in humans. In cross-sectional stud-
ies, higher levels of EDCs such as BPA and 
phthalates have been reported in obese than 
in normal-weight subjects, although because 
these EDCs are fat soluble, it is not clear 
whether this partly reflects larger adipose tis-
sue depots in fatter subjects (Lang et al. 2008; 
Stahlhut et al. 2007).
DDE, a metabolite of the pesticide DDT, 
has not been explored in animal studies on 
environmental obesogens. However, experi-
mental data indicate that DDE does modu-
late endocrine function and influences gene 
expression after binding to nuclear receptors 
(Li et al. 2008; Sonnenschein and Soto 1998). 
Although DDT use is prohibited in most 
industrialized countries, including Spain, 
high concentrations of DDE continue to be 
reported in human biomarker studies because 
of its long half-life and persistence in water, 
sediments, and the food chain. DDE levels 
in this sample were similar to those reported 
both among pregnant women by Verhulst 
et al. (2009) and in first-trimester samples 
in the U.S. National Health and Nutrition 
Examination Survey (Wang et al. 2009).
Other than DDE, the OCs examined in 
this study were not independently associated 
with either rapid early weight gain or BMI at 
14 months. For PCBs, the absence of asso-
ciation is consistent with data from Karmaus 
et al. (2009), although Verhulst et al. (2009) 
reported a very small increase in BMI z-scores 
associated with PCB exposure (0.003 for 
each 1-ng/g increase). Verhulst et al. (2009) 
reported HCB exposure in a range similar to 
those in our sample to be unassociated with 
BMI through 3 years of age. Prenatal HCB 
levels here were three times lower than in a 
previous study (Smink et al. 2008) report-
ing an association with later childhood obe-
sity (median, 0.25 vs. 0.68 ng/mL). Further 
research is needed to ascertain whether dis-
parities in exposure levels or different mecha-
nisms of action for either individual OCs or 
mixtures might explain why we observed sig-
nificant positive associations only for DDE.
Excluding SGA or low-birth-weight 
infants had little influence; indeed, results 
were slightly strengthened after excluding 
either group. This is important given that 
rapid early growth was initially thought to 
increase obesity risk predominantly in SGA 
infants, who might be programmed in utero to 
use dietary energy efficiently, perhaps increas-
ing susceptibility to excess weight gain when 
exposed to energy-dense foods and sedentary 
environments (Dunger and Ong 2005). It is 
now evident, however, that rapid early weight 
gain is linked with obesity among infants of 
average size (Karaolis-Danckert et al. 2006; 
Leunissen et al. 2009).
None of the small number of infants 
at the very highest levels of maternal DDE 
exposure (> 750 ng/g), primarily of foreign-
born mothers, experienced rapid growth in 
the first 6 months. We cannot determine 
whether this occurred by chance, or whether 
very highly exposed children might be at 
reduced risk of rapid weight gain. However, 
similar opposing patterns of risk at low ver-
sus high exposure levels have been reported 
in other studies on health effects of xeno-
estrogens (Wadia et al. 2007; Weltje et al. 
2005). Reasons for the differential associa-
tions between fetal DDE exposure and rapid 
growth by maternal prepregnancy weight sta-
tus are also uncertain; although the sample 
was small, associations between DDE and 
early rapid growth appeared to be negative 
among overweight mothers. In our study, 
children of obese mothers were at increased 
risk of overweight for reasons independent of 
chemical exposures: these infants had higher 
weight and BMI z-scores at birth and at 6 and 
14 months of age regardless of prenatal DDE 
levels (data not shown). Experimental evi-
dence suggests that offspring of obese mothers 
may be at increased risk of obesity, possibly 
due to genetic susceptibility or perhaps to 
epigenetic changes (Waterland et al. 2008; 
Wu and Suzuki 2006). For example, lower 
intakes of nutrients such as folate, which has 
been reported among obese pregnant women 
(Rifas-Shiman et al. 2009), may increase risk 
of offspring obesity, given animal studies 
showing dietary supplementation with methyl 
donors including folate to be associated with 
reduced body weight in subsequent genera-
tions (Waterland et al. 2008). Animal studies 
have also reported stronger obesogenic effects 
of high-fat diets in offspring of obese than of 
normal-weight mothers (White et al. 2009). 
Moreover, observational studies have reported 
breast-feeding to be more strongly protec-
tive against child obesity among overweight 
mothers than among normal-weight mothers 
(Li et al. 2005). Very early growth patterns 
among infants of overweight and obese moth-
ers may, therefore, be more strongly related to 
factors other than OC exposure.
Although interactions with child sex 
did not reach significance either overall or 
after stratifying by maternal weight status 
(p > 0.10), associations between DDE and 
rapid growth were stronger in boys. Some 
studies have suggested that effects of peri-
conceptional exposures to EDCs and other 
factors may be sex-specific (Gabory et al. 
2009; Tobi et al. 2009). The modest sample 
size may have lacked power to detect statisti-
cally significant interactions.
Although prenatal DDE exposure was 
associated with rapid weight gain and BMI, 
no direct measures of adiposity were available. 
However, previous studies have reported that 
rapid weight gain was more strongly associ-
ated with direct measures of body fatness than 
with BMI (Holzhauer et al. 2009; Karaolis-
Danckert et al. 2006). We measured prenatal 
DDE only in maternal serum collected in 
early pregnancy; levels have been observed 
to increase later in pregnancy because of 
metabolic changes during gestation (Torres-
Sánchez et al. 2007; Wang et al. 2009). 
However, studies using repeated measures 
from multiple trimesters have found that only 
first-trimester DDE was associated with early 
neurodevelopment and genital structure alter-
ations (Torres-Sánchez et al. 2007, 2008). 
Although potential mechanisms are uncertain, 
associations with first-trimester measures are 
consistent with hypotheses involving epige-
netic changes, because such effects have been 
observed to be more frequent for pericon-
ceptional than for later exposures (Lee et al. 
2009; Tobi et al. 2009). Other limitations 
include the modest sample size, resulting in 
few rapid growers in the referent group and 
fairly wide conference intervals. An important 
strength is the large number of potential con-
founders considered, including birth weight 
and weight gain in pregnancy, which were 
only weakly (Spearman’s r < 0.10) correlated 
with prenatal DDE and did not confound 
associations. Although follow-up thus far is 
short, future analyses will assess longer-term 
effects of OCs on postnatal growth.
Conclusion
We found that among normal-weight moth-
ers, prenatal DDE exposure was associated 
with an increased risk of rapid growth in the 
first 6 months of life, as well as elevated BMI 
at 14 months. Other OCs examined were not 
associated with increased risk of rapid growth. Prenatal organochlorines and growth
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Given the large body of evidence indicating 
that rapid weight gain in the first months of 
life increases long-term risk of obesity and 
metabolic disorders, these data provide sup-
port for a possible role of prenatal exposure to 
DDE in programming these health problems. 
Future research is needed to assess whether 
the association may be causal and what the 
underlying mechanisms might be.
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